Immediate Impact

37 standout
Sub-graph 1 of 19

Citing Papers

Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
2024 Standout
Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
2024 Standout
2 intermediate papers

Works of D. de Argila being referenced

Determinación de la dosis eritemática mínima y reacciones anómalas a radiación ultravioleta A según fototipo
2014
Determination of Minimal Erythema Dose and Anomalous Reactions to UVA Radiation by Skin Phototype
2014
and 2 more

Author Peers

Author Last Decade Papers Cites
D. de Argila 299 159 110 116 71 587
Yueping Zeng 158 140 132 70 71 593
John Almeyda 180 119 92 78 37 514
H Bergoend 216 184 186 113 62 630
Philippe Moguelet 158 134 90 80 69 660
Anuradha Bishnoi 213 128 106 105 114 589
O. Chosidow 397 145 143 52 50 695
Muskaan Sachdeva 466 73 79 60 85 680
A. Pérez‐Ferriols 395 96 116 212 100 685
É. Bégon 286 149 146 283 45 680
Scott Worswick 225 102 135 68 65 611

All Works

Loading papers...

Rankless by CCL
2026